tldrdailynews.com logo

Metsera's Amylin Drug Shows Promising Weight Loss Results

1 min read
Source: statnews.com
Metsera's Amylin Drug Shows Promising Weight Loss Results
Photo: statnews.com
TL;DR

Metsera's experimental obesity drug targeting amylin shows promising early results, with significant weight loss observed in initial trials, suggesting it may offer longer-lasting effects than current weekly injections.

Topics:businesshealth#amylin#clinical-trial#health#metsera#obesity#weight-loss
Share this article
  1. Metsera’s amylin drug shows early potential for substantial weight loss  statnews.com
  2. Obesity Startup Metsera Shares Rise on Early-Stage Trial Results  Bloomberg
  3. Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch  Investor's Business Daily
  4. Metsera posts weight loss data for amylin analog, teeing up monthly GLP-1 combo plans  Fierce Biotech
  5. Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i  Yahoo Finance

Want the full story? Read the original reporting

Read on statnews.com